Optical coherence tomography: a window to the optic nerve in clinically isolated syndrome

In this study, we aimed to evaluate the association of asymptomatic optic nerve demyelinating lesion in patients presenting a clinically isolated syndrome with the asymptomatic retinal neuro-axonal loss previously reported at clinically isolated syndrome. We prospectively recruited 66 patients presenting a clinically isolated syndrome and 66 healthy control subjects matched according to age and gender. All patients underwent brain magnetic resonance imaging including 3D-double inversion recovery (DIR) sequence, optical coherence tomography examination and visual function evaluation, at 2.5-4.5 months after CIS. Evaluation criteria were presence and length of optic nerve DIR hypersignal, retinal layers (including ganglion cell inner plexiform layer and inner nuclear layer) thickness/volume, and low contrast monocular vision acuity (number of letters correctly identified). All clinically isolated syndrome eyes with past history of optic neuritis (CIS-ON) presented an optic nerve DIR hypersignal. We observed asymptomatic optic nerve DIR hypersignal in 22.2% of clinically isolated syndrome eyes without optic neuritis (CIS-NON). In comparison with healthy control, GCIPL volume (in mm3) was significantly lower in CIS-ON eyes [β (95% confidence interval, CI) = -0.121 (-0.168 to -0.074); P < 0.0001], and to a lesser extent in CIS-NON [β (95% CI) = -0.023 (-0.039 to -0.008); P = 0.004]. In comparison to healthy controls, eyes with asymptomatic optic nerve DIR hypersignal presented significantly lower macular ganglion cell inner plexiform layer volume [β (95% CI) = -0.043 (-0.068 to -0.019); P = 0.001], and eyes without did not [β (95% CI) = -0.016 (-0.034 to 0.003); P = 0.083]. Among CIS-NON, macular ganglion cell inner plexiform layer volume decrease was associated with asymptomatic optic nerve DIR hypersignal independently of optic radiations T2 lesions and primary visual cortex volumes (P = 0.012). Symptomatic optic nerve DIR hypersignal were significantly longer (13.8 ± 6.7 mm) than asymptomatic optic nerve hypersignal (10.0 ± 5.5 mm; P = 0.047). Length of optic nerve DIR hypersignal was significantly associated with thinner inner retinal layers (P ≤ 0.001), thicker inner nuclear layer (P = 0.017) and lower low contrast monocular vision acuity (P < 0.05). Compared to healthy control, low contrast monocular vision acuity was significantly lower in CIS-ON eyes (P < 0.0001) and CIS-NON eyes with (P = 0.03) or without asymptomatic optic nerve DIR hypersignal (P = 0.0005). Asymptomatic demyelinating optic nerve DIR hypersignal at the earliest clinical stage of multiple sclerosis is frequent and associated with asymptomatic retinal neuro-axonal loss reported at clinically isolated syndrome stage. Length of optic nerve DIR hypersignal is a biomarker of retinal neuro-axonal loss and visual disability at clinically isolated syndrome stage. Visual disability of clinically isolated syndrome eyes without clinical and subclinical optic nerve involvement might be due to missed optic nerve lesions on MRI. At the earliest clinical stage of multiple sclerosis, our results support considering optical coherence tomography as a window to the optic nerve rather than to the brain.

[1]  M. Larsen,et al.  Neither retinal nor brain atrophy can be shown in patients with isolated unilateral optic neuritis at the time of presentation , 2011, Multiple sclerosis.

[2]  P. Vermersch,et al.  Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss , 2016, Multiple sclerosis.

[3]  M. Wyss,et al.  How Common Is Signal-Intensity Increase in Optic Nerve Segments on 3D Double Inversion Recovery Sequences in Visually Asymptomatic Patients with Multiple Sclerosis? , 2017, American Journal of Neuroradiology.

[4]  G. Plant,et al.  Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria , 2015, Multiple sclerosis.

[5]  R. Kardon,et al.  Quantifying axonal loss after optic neuritis with optical coherence tomography , 2006 .

[6]  Alexander Klistorner,et al.  Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis , 2017, The Lancet Neurology.

[7]  J. Alvarez-Linera,et al.  Clinically Isolated Syndromes Suggestive of Multiple Sclerosis: An Optical Coherence Tomography Study , 2012, PloS one.

[8]  A. Jackson,et al.  Optic neuritis: MR imaging with combined fat- and water-suppression techniques. , 1998, Radiology.

[9]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[10]  P. Vermersch,et al.  Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss. , 2009, Archives of neurology.

[11]  Hakmook Kang,et al.  Incorporating dixon multi‐echo fat water separation for novel quantitative magnetization transfer of the human optic nerve in vivo , 2017, Magnetic resonance in medicine.

[12]  B E Kendall,et al.  Magnetic resonance imaging of the optic nerve in optic neuritis , 1988, Neurology.

[13]  C. Crainiceanu,et al.  Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study , 2012, The Lancet Neurology.

[14]  P. Mogensen.  Histopathology of anterior parts of the optic pathway in patients with multiple sclerose , 1990, Acta ophthalmologica.

[15]  P. Vermersch,et al.  Optic nerve double inversion recovery hypersignal in patients with clinically isolated syndrome is associated with asymptomatic gadolinium-enhanced lesion , 2018, Multiple sclerosis.

[16]  F. Paul,et al.  Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome , 2018, JAMA neurology.

[17]  G. Plant,et al.  The time course of retrograde trans-synaptic degeneration following occipital lobe damage in humans. , 2012, Brain : a journal of neurology.

[18]  P. Vermersch,et al.  Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study , 2014, European Radiology.

[19]  M. Platten,et al.  Klinisch isoliertes Syndrom , 2013, Der Nervenarzt.

[20]  F. Barkhof,et al.  Postmortem verification of MS cortical lesion detection with 3D DIR , 2012, Neurology.

[21]  A. Doerfler,et al.  Baseline Magnetic Resonance Imaging of the Optic Nerve Provides Limited Predictive Information on Short-Term Recovery after Acute Optic Neuritis , 2015, PloS one.

[22]  M. Kupersmith,et al.  Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. , 2002, Brain : a journal of neurology.

[23]  Sabine Defoort-Dhellemmes,et al.  A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis , 2015, Multiple sclerosis.

[24]  M. Mühlau,et al.  Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. , 2016, Brain : a journal of neurology.

[25]  Sara Llufriu,et al.  Trans‐synaptic axonal degeneration in the visual pathway in multiple sclerosis , 2014, Annals of neurology.

[26]  O. Ciccarelli,et al.  Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study , 2017, The Lancet Neurology.

[27]  M. Sormani,et al.  Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis , 2017, PloS one.

[28]  M. Bähr,et al.  Decreased amplitudes in multiple sclerosis patients with normal visual acuity: a VEP study , 2003, Journal of Clinical Neuroscience.

[29]  G. Barker,et al.  Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI , 1996, Neuroradiology.

[30]  Alexander Klistorner,et al.  Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study , 2016, The Lancet Neurology.

[31]  Bernhard Hemmer,et al.  Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination , 2016, Multiple sclerosis.

[32]  Sven Schippling,et al.  Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome , 2013, Multiple sclerosis.

[33]  S. Dunker,et al.  Prognostic value of magnetic resonance imaging in monosymptomatic optic neuritis. , 1996, Ophthalmology.

[34]  P M Matthews,et al.  Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. , 2001, Brain : a journal of neurology.

[35]  Stephen J. Jones,et al.  Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis , 2005, Annals of neurology.

[36]  O. Périer,et al.  Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. , 1983, Journal of clinical neuro-ophthalmology.

[37]  A. Green,et al.  Microcystic macular oedema in multiple sclerosis is associated with disease severity. , 2012, Brain : a journal of neurology.

[38]  M. Mühlau,et al.  Detecting optic nerve lesions in clinically isolated syndrome and multiple sclerosis: double-inversion recovery magnetic resonance imaging in comparison with visually evoked potentials , 2018, Journal of Neurology.

[39]  O. Ciccarelli,et al.  Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis , 2018, Neurology.

[40]  David H. Miller,et al.  Clinically isolated syndromes , 2012, The Lancet Neurology.

[41]  M. Mühlau,et al.  Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis , 2017, JAMA neurology.

[42]  A. J. Thompson,et al.  Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis , 2009, Journal of Neurology.

[43]  C. Pérez-Rico,et al.  Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients. , 2014, Investigative ophthalmology & visual science.

[44]  Jacqueline Palace,et al.  Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography , 2015, Multiple sclerosis.